BTIG analyst Thomas Shrader maintained a Buy rating on Ovid Therapeutics (OVID – Research Report) yesterday and set a price target of $5.00. Thomas Shrader’s rating is based on a combination ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

Covid-19 continues to be a powerful risk factor for future heart attacks and strokes for almost three years following the ...

New data from the CDC reveals a northward shift in the highest detection levels, with significant variability between ...

MONTROSE, Mich. (WJRT) - Ovid-Elsie defeated Montrose, 42-7, to secure its first 5-0 start to a season since 2009.

Polo Bear Slippers that are currently 20 percent off. There are four grown men in my immediate family to get gifts for. My ...

STD testing can be quick, painless, and sometimes even free. STD testing isn’t usually included in regular medical exams — you have to ask for it. Please enter your age and the first day of your last ...